The strategic goal of DISCOvERIE is to provide an enhanced understanding on IBS (Irritable Bowel Syndrome) and comorbidities and their risk factors. It will develop a personalised medicine solution to the problem by providing a thorough clinical and psychosocial characterization of IBS patients.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 848228) and will last 5 years (2020-2024)
